Sort
48,018 grants matching “immunotherapy”
Correction of diabetic retinopathy by mitochondrial transfer
$538,307Denis A Proshlyakov · Michigan State University · R01 · FY2024 · EY
Targeted Therapies for Lymphoid Malignancies
$538,241Jennifer A. Woyach · Ohio State University · R01 · FY2025 · CA
Targeted Therapies for Lymphoid Malignancies
$538,241Jennifer A. Woyach · Ohio State University · R01 · FY2021 · CA
Targeting tumor-associated macrophages for triple-negative breast cancer treatment
$538,218Mingye Feng · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS
$538,200University Of Pittsburgh At Pittsburgh · R01 · FY2002 · AI
COMBINATION OF P53 MRNA NANOTHERAPY WITH IMMUNOTHERAPY FOR LIVER CANCER TREATMENT
$538,146Brigham & Womens Hospital Inc · · FY2019 · Department of the Army
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
$538,057Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2025 · AI
Pro-tumorigenic functions of human DNA polymerases eta and kappa during genome duplication under physiological replication stress conditions
$537,971Kristin A Eckert · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$537,921Zihai Li · Ohio State University · R01 · FY2023 · CA
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$537,900Anna Pomes · Indoor Biotechnologies · R01 · FY2023 · AI
Epigenetic and immunologic aspects of neuroendocrine cancers
$537,880Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
$537,878Robert J. Canter · University Of California At Davis · U01 · FY2021 · CA
Understanding human neutralizing antibodies to hepatitis C virus
$537,865Mansun Law · Scripps Research Institute, The · R01 · FY2013 · AI
Career Development in Pediatric and Medical Oncology
$537,840Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2008 · CA
Career Development in Pediatric and Medical Oncology
$537,840Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2006 · CA
Career Development in Pediatric and Medical Oncology
$537,840Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2007 · CA
Career Development in Pediatric and Medical Oncology
$537,840Fred Hutchinson Cancer Research Center · K12 · FY2005 · CA
Career Development in Pediatric and Medical Oncology
$537,840Fred Hutchinson Cancer Research Center · K12 · FY2004 · CA
Metabolic Impacts of Type II Interferon Signals in Obesity
$537,838Sean Hartig · Baylor College Of Medicine · R01 · FY2023 · DK
Chemotherapy and the Bladder Cancer Immune Microenvironment
$537,831William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
High Performance Magnetic Cell Sorting
$537,818Jeffrey John Chalmers · Ohio State University · R01 · FY2006 · CA
UCSF Project 1
$537,768Trever G Bivona · University Of California, San Francisco · U54 · FY2020 · CA
Acoustothermogenetics for Cell Engineering
$537,740Yingxiao Wang · University Of Southern California · R35 · FY2023 · GM
Development of Antigen-specific B Cell Memory
$537,706Michael G. McHeyzer-Williams · Scripps Research Institute, The · R01 · FY2014 · AI
NextGen - CHOP
$537,702John M Maris · Children'S Hosp Of Philadelphia · OT2 · FY2023 · CA